Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. more
Time Frame | SNY | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1.94% | -2.12% | -3% |
1-Month Return | -0.15% | -3.42% | -0.73% |
3-Month Return | -17.21% | -11.13% | 2.87% |
6-Month Return | 1.84% | -5.74% | 7.17% |
1-Year Return | -1.04% | 3.97% | 25.31% |
3-Year Return | -2.57% | 1.05% | 28.38% |
5-Year Return | -5.62% | 34.37% | 81.89% |
10-Year Return | 3.81% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 37.63B | 37.37B | 39.17B | 45.39B | 46.03B | [{"date":"2019-12-31","value":81.75,"profit":true},{"date":"2020-12-31","value":81.18,"profit":true},{"date":"2021-12-31","value":85.1,"profit":true},{"date":"2022-12-31","value":98.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 11.98B | 12.16B | 12.26B | 13.69B | 14.24B | [{"date":"2019-12-31","value":84.15,"profit":true},{"date":"2020-12-31","value":85.4,"profit":true},{"date":"2021-12-31","value":86.08,"profit":true},{"date":"2022-12-31","value":96.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 25.65B | 25.21B | 26.92B | 31.70B | 31.80B | [{"date":"2019-12-31","value":80.67,"profit":true},{"date":"2020-12-31","value":79.29,"profit":true},{"date":"2021-12-31","value":84.66,"profit":true},{"date":"2022-12-31","value":99.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 68.17% | 67.47% | 68.72% | 69.83% | 69.07% | [{"date":"2019-12-31","value":97.61,"profit":true},{"date":"2020-12-31","value":96.61,"profit":true},{"date":"2021-12-31","value":98.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.91,"profit":true}] |
Operating Expenses | 18.47B | 17.32B | 17.77B | 19.81B | 23.94B | [{"date":"2019-12-31","value":77.16,"profit":true},{"date":"2020-12-31","value":72.34,"profit":true},{"date":"2021-12-31","value":74.23,"profit":true},{"date":"2022-12-31","value":82.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 3.05B | 8.08B | 8.13B | 16.79B | 7.88B | [{"date":"2019-12-31","value":18.17,"profit":true},{"date":"2020-12-31","value":48.12,"profit":true},{"date":"2021-12-31","value":48.39,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":46.89,"profit":true}] |
Total Non-Operating Income/Expense | (4.43B) | (313.00M) | (656.00M) | (400.00M) | (1.36B) | [{"date":"2019-12-31","value":-442900000000,"profit":false},{"date":"2020-12-31","value":-31300000000,"profit":false},{"date":"2021-12-31","value":-65600000000,"profit":false},{"date":"2022-12-31","value":-40000000000,"profit":false},{"date":"2023-12-31","value":-136100000000,"profit":false}] |
Pre-Tax Income | 2.75B | 13.80B | 7.80B | 10.49B | 7.15B | [{"date":"2019-12-31","value":19.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":56.49,"profit":true},{"date":"2022-12-31","value":75.99,"profit":true},{"date":"2023-12-31","value":51.82,"profit":true}] |
Income Taxes | 121.00M | 1.81B | 1.56B | 2.01B | 1.60B | [{"date":"2019-12-31","value":6.03,"profit":true},{"date":"2020-12-31","value":90.38,"profit":true},{"date":"2021-12-31","value":77.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":79.86,"profit":true}] |
Income After Taxes | 2.63B | 11.99B | 6.24B | 8.48B | 5.55B | [{"date":"2019-12-31","value":21.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":52.04,"profit":true},{"date":"2022-12-31","value":70.75,"profit":true},{"date":"2023-12-31","value":46.29,"profit":true}] |
Income From Continuous Operations | 2.94B | 12.35B | 6.28B | 6.83B | 5.44B | [{"date":"2019-12-31","value":23.79,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.84,"profit":true},{"date":"2022-12-31","value":55.33,"profit":true},{"date":"2023-12-31","value":44.02,"profit":true}] |
Income From Discontinued Operations | (101.00M) | - | - | - | - | [{"date":"2019-12-31","value":-10100000000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 2.75B | 12.29B | 6.22B | 8.37B | 5.40B | [{"date":"2019-12-31","value":22.4,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":50.62,"profit":true},{"date":"2022-12-31","value":68.09,"profit":true},{"date":"2023-12-31","value":43.92,"profit":true}] |
EPS (Diluted) | 3.17 | 3.41 | 3.87 | 4.32 | 5.77 | [{"date":"2019-12-31","value":54.94,"profit":true},{"date":"2020-12-31","value":59.1,"profit":true},{"date":"2021-12-31","value":67.07,"profit":true},{"date":"2022-12-31","value":74.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SNY | |
---|---|
ROA (LTM) | 4.16% |
ROE (LTM) | 5.82% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SNY | |
---|---|
Trailing PE | 25.13 |
Forward PE | 10.48 |
P/S (TTM) | 2.49 |
P/B | 1.56 |
EV/R | 2.69 |
EV/Ebitda | 14.54 |
PEG | 0.73 |
Sanofi ADR (SNY) share price today is $47.71
Yes, Indians can buy shares of Sanofi ADR (SNY) on Vested. To buy Sanofi ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SNY stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Sanofi ADR (SNY) via the Vested app. You can start investing in Sanofi ADR (SNY) with a minimum investment of $1.
You can invest in shares of Sanofi ADR (SNY) via Vested in three simple steps:
The 52-week high price of Sanofi ADR (SNY) is $58.97. The 52-week low price of Sanofi ADR (SNY) is $45.22.
The price-to-earnings (P/E) ratio of Sanofi ADR (SNY) is 24.873
The price-to-book (P/B) ratio of Sanofi ADR (SNY) is 1.56
The dividend yield of Sanofi ADR (SNY) is 4.33%
The market capitalization of Sanofi ADR (SNY) is $120.92B
The stock symbol (or ticker) of Sanofi ADR is SNY